Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Skinbiotherap. (SBTX) Share News

IN BRIEF: SkinBioTherapeutics to launch AxisBiotix-Ps in Italy

21st Jun 2023 10:48

SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Receives regulatory approval to issue AxisBiotix-Ps in Italy. This follows the launch of AxisBiotix-Ps in Spain, after having received approval in March. Says the next target country for launch of the product is France, with talks with French regulators already underway. AxisBiotix-Ps is a food supplement used to alleviate Psoriasis symptoms. Read More

IN BRIEF: SkinBioTherapeutics knows no reason for share price fall

14th Jun 2023 18:24

SkinBioTherapeutics PLC - life science company focused on skin health - Notes share price slide but says "not aware of any rationale for the movement". Read More

SkinBioTherapeutics says Sederma to undertake more SkinBiotix studies

10th May 2023 11:59

(Alliance News) - SkinBioTherapeutics PLC on Wednesday said that a partner has plans to undertake additional studies on SkinBiotix, which could enhance its commercial potential. Read More

IN BRIEF: SkinBioTherapeutics shares plunge on widened interim loss

28th Mar 2023 12:25

SkinBioTherapeutics PLC - skin health-focused life sciences firm - Says interim revenue jumps to GBP76,985 in the six months to December 31, from GBP21,949 a year before. Pretax loss widens to GBP1.4 million from GBP1.2 million, as operational costs climb to GBP918,103 from GBP764,750. In 2023, says focus is on reaching commercial traction with Croda, launching AxisBiotix-Ps into Europe, developing an acne product, among others targets. Read More

AIM WINNERS & LOSERS: Unbound soars on potential takeover offer

28th Mar 2023 10:40

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

SkinBioTherapeutics receives Spanish health approval for AxisBioTix-Ps

7th Mar 2023 12:36

(Alliance News) - SkinBioTherapeutics PLC on Tuesday said it received Spanish health authority authorisation for AxisBioTix-Ps, its food supplement to treat symptoms associated with psoriasis. Read More

UK shareholder meetings calendar - next 7 days

23rd Jan 2023 15:48

UK shareholder meetings calendar - next 7 days

22nd Dec 2022 15:44

UPDATE: SkinBioTherapeutics raises GBP2.6 million; annual loss widens

21st Dec 2022 11:06

(Alliance News) - SkinBioTherapeutics PLC on Wednesday said it raised GBP2.6 million in total through its share placing and retail offer. Read More

SkinBioTherapeutics raises GBP2.6 million from placing, retail offer

21st Dec 2022 10:59

(Alliance News) - SkinBioTherapeutics PLC on Wednesday said it raised GBP2.6 million in total through its share placing and retail offer. Read More

TRADING UPDATES: Dev Clever to cancel shares; Tintra raises funds

16th Dec 2022 21:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

SkinBioTherapeutics shares fall as probiotic AxisBiotix-PS sales drop

31st Aug 2022 12:55

(Alliance News) - SkinBioTherapeutics PLC on Wednesday said the sales of its psoriasis food supplement AxisBiotix-PS were lower than expected and said it found a form of bacteria that prevents gum disease. Read More

OptiBiotix shares plunge on "very difficult trading" in half-year

24th Aug 2022 10:43

(Alliance News) - OptiBiotix Health PLC on Wednesday lamented a strenuous half-year but eyed growing sales and business, seeing itself in a strong position. Read More

IN BRIEF: OptiBiotix Health annual profit up; confident in prospects

28th Jun 2022 12:19

OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Reports higher profit and revenue in 2021 as probiotic business sells more. Pretax profit rises to GBP6.2 million from GBP5.7 million in 2020. Revenue from contracts with customers grows 45% to GBP2.2 million from GBP1.5 million. Read More

IN BRIEF: SkinBioTherapeutics unaware of reason for share price drop

13th Jun 2022 20:24

SkinBioTherapeutics PLC- Skin health-focused life sciences company - Says it is not aware of any "material commercial or operational" reason for the fall in its share price on Monday. Adds that it continues to focus on driving sales of its AxisBiotix-Ps probiotic food supplement, which holds a subscriber-retention rate of more than 80%. Read More

IN BRIEF: SkinBioTherapeutics loss widens as underperforms in US

29th Mar 2022 13:39

SkinBioTherapeutics PLC- Skin health-focused life sciences company - Says pretax loss widens to GBP1.2 million in six months to December 31, from GBP628,241 a year earlier. US market penetration with its only product launched in October 2021, AxisBiotix-Ps, for treating Psoriasis, was slower than expected, company adds. Revenue for the half comes in at GBP21,949, against none a year earlier. For the financial year ending in June, the company expects revenue materially below expectations, it warns. Read More

FTSE 100 Latest

Value9,645.62

Change67.05